• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    8/21/24 6:07:51 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology
    Get the next $AIFF alert in real time by email
    SC 13G 1 d889435dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

     

     

    FIREFLY NEUROSCIENCE, INC.

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    317970101

    (CUSIP Number)

    August 12, 2024

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications:

    Rick Werner, Esq.

    Haynes and Boone, LLP

    30 Rockefeller Plaza, 26th Floor

    New York, New York 10112

    (212) 659-7300

     

     

     


    SCHEDULE 13G

    CUSIP No. 317970101

     

     1   

     Names of Reporting Persons

     

     RJL 18 Capital Canada LP

     2  

     Check the appropriate box if a member of a Group (see instructions)

     

     (a) ☐  (b) ☐

     3  

     Sec Use Only

     

     4  

     Citizenship or Place of Organization

     

     Ontario

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5   

     Sole Voting Power

     

     499,369

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     499,369

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     499,369

    10  

     Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

     

     ☐

    11  

     Percent of class represented by amount in row (9)

     

     6.2%

    12  

     Type of Reporting Person (See Instructions)

     

     PN


    Item 1.

     

    (a)

    Name of Issuer:

    Firefly Neuroscience, Inc. (the “Issuer”)

     

    (b)

    Address of Issuer’s Principal Executive Offices:

    1100 Military Road

    Kenmore, NY 14217

     

    Item 2.

     

    (a)

    Name of Person Filing:

    RJL 18 Capital Canada LP

     

    (b)

    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of the reporting person is 150 King Street, West 200, Toronto, Canada M5H 1J9.

     

    (c)

    Citizenship:

    See Item 4 on the cover page(s) hereto.

     

    (d)

    Title and Class of Securities:

    Common Stock, par value $0.0001 per share (“Common Stock”)

     

    (e)

    CUSIP No.:

    317970101

     

    Item 3.

    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)    ☐    Broker or dealer registered under Section 15 of the Act;
    (b)    ☐    Bank as defined in Section 3(a)(6) of the Act;
    (c)    ☐    Insurance company as defined in Section 3(a)(19) of the Act;
    (d)    ☐    Investment company registered under Section 8 of the Investment Company Act of 1940;
    (e)    ☐    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
    (f)    ☐    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
    (g)    ☐    A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
    (h)    ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);


    (i)    ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
    (j)    ☐    A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
    (k)    ☐    Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
             

     

    Item 4.

    Ownership

     

    (a)

    Amount Beneficially Owned as of the time of filing: See Item 9 on the cover pages(s) hereto.

     

    (b)

    Percent of Class as of the time of filing: See Item 11 on the cover page(s) hereto.

     

    (c)

    As of the time of filing, number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: See Item 5 on the cover pages hereto.

     

      (ii)

    Shared power to vote or to direct the vote: See Item 6 on the cover pages hereto.

     

      (iii)

    Sole power to dispose or to direct the disposition of: See Item 7 on the cover pages hereto.

     

      (iv)

    Shared power to dispose or to direct the disposition of: See Item 8 on the cover pages hereto.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following ☐.

     

    Item 6.

    Ownership of more than Five Percent on Behalf of Another Person.

    Not applicable

     

    Item 7.

    Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

    Not applicable

     

    Item 8.

    Identification and classification of members of the group.

    Not applicable

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable

     

    Item 10.

    Certifications.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under § 240.14a-11.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: August 21, 2024

     

    RJL 18 CAPITAL CANADA LP
    By:  

    /s/ Dean Lazer

    Name:   Dean Lazer
    Title:   Authorized Signatory
    Get the next $AIFF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AIFF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AIFF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

      A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc., released on May 5, 2025 at 8:00 am ET. Please note, the correct form of payment of the potential Evoke investors' earn-out is in Firefly's common stock. The complete corrected press release follows: Builds upon Firefly's recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company")

      5/5/25 9:00:00 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

      Builds upon Firefly's recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announce its acquisition of Evoke Neuroscience, Inc. ("Evoke"), a medical device company developing and commercializing technologies to aid in the comprehensive assessment of brain health. The transaction marks another important step toward

      5/5/25 7:45:00 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

      KENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announced that it has received total proceeds of $8,824,710 from the exercise of warrants to purchase 823,530 shares of the common stock of the Company, par value $0.0001 per share ("common stock"), at an exercise price of $6.83, and warrants to purchase 800,000 shares of commons stock, at an exercise price of $4.00, respectively. The warrants were issued pursuant to private placements that closed

      2/21/25 8:00:00 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Menawat Arun Swarup

      4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

      5/20/25 7:13:48 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 4 filed by CEO Lipschitz Gregory

      4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

      4/22/25 7:09:21 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 4 filed by President and COO Decaprio David

      4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

      4/22/25 7:08:38 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    Leadership Updates

    Live Leadership Updates

    See more
    • Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

      TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of current director of the Board, Greg Lipschitz, as Executive Chairman, effective as of December 3, 2024. "I look forward to taking on a more active leadership role as Executive Chairman," said Greg Lipschitz, newly appointed Executive Chairman of Firefly. "I believe that Firefly is uniquely positioned at the intersection of artificial intelligence and brain health that I have l

      12/4/24 9:00:00 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

      TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024. Dr. Vnook will serve as Chairperson of the Nominating Committee. Dr. Vnook brings over 25 years of experience as a distinguished pharmaceutical executive, serial entrepreneur, CEO and founder of multiple biotech companies and visionary leader with a track record of success in biotechnology and life

      9/5/24 9:00:00 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    Financials

    Live finance-specific insights

    See more
    • Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

      Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering wi

      11/14/24 5:30:18 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    SEC Filings

    See more
    • SEC Form S-8 filed by Firefly Neuroscience Inc.

      S-8 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

      5/21/25 9:22:27 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-Q filed by Firefly Neuroscience Inc.

      10-Q - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

      5/14/25 6:02:18 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • Firefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

      5/5/25 6:20:09 AM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology

    $AIFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Firefly Neuroscience Inc.

      SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

      9/19/24 9:48:56 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G filed by Firefly Neuroscience Inc.

      SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

      8/21/24 6:07:51 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G filed by Firefly Neuroscience Inc.

      SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

      8/21/24 6:03:49 PM ET
      $AIFF
      Computer Software: Prepackaged Software
      Technology